Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04919824 · ClinicalTrials.gov registry record · NA
Monopolar Current Cutting Knife vs Bipolar RFA Knife
A NA study of Gastrointestinal Neoplasms, sponsored by Baylor College of Medicine.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT04919824: Active NA study of Gastrointestinal Neoplasms, sponsored by Baylor College of Medicine.
NCT04919824 is a NA study of Gastrointestinal Neoplasms that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 80 participants, below the 960-participant average among 12 other Gastrointestinal Neoplasms trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04919824, a NA study of Gastrointestinal Neoplasms, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, randomized trial that aims to study the efficacy and clinical outcomes of a novel Bipolar Knife vs. Monopolar Knives on patients who undergo endoscopic submucosal dissection (ESD) procedure at Baylor St. Luke's Medical Center.
Primary Outcome
The speed of endoscopic submucosal dissection as calculated by cm2/hour
Conditions Studied
Interventions
- PROCEDURE Endoscopic Submucosal Dissection
- PROCEDURE Endoscopic Mucosal Resection
Study Locations (2)
Texas
- Baylor College of Medicine - Houston
- Baylor St. Lukes Medical Center (BSLMC) - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-01-25 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
What the registry record for NCT04919824 still lists
NCT04919824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 960-participant average among 12 other Gastrointestinal Neoplasms trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Gastrointestinal Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Endoscopic Submucosal Dissection is the first listed.
NCT04919824 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04919824 about?
NCT04919824 is a clinical study titled "Monopolar Current Cutting Knife vs Bipolar RFA Knife". This is a prospective, randomized trial that aims to study the efficacy and clinical outcomes of a novel Bipolar Knife vs. Monopolar Knives on patients who undergo endoscopic submucosal dissection (ESD) procedure at Baylor St. Luke's Medical Center.
What is the current status of trial NCT04919824?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-01-25. Estimated completion is 2025-10-30.
What conditions does trial NCT04919824 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasms.
What interventions are being tested in trial NCT04919824?
The interventions under investigation include: Endoscopic Submucosal Dissection (PROCEDURE), Endoscopic Mucosal Resection (PROCEDURE).
Who is sponsoring clinical trial NCT04919824?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04919824 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04919824's enrollment target sits among peer trials
80 9th of 12 higher than 4 of 12 other Gastrointestinal Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
ACTIVE NOT RECRUITING · NA
-
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
RECRUITING · Phase 1
-
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RECRUITING · Phase 3
-
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
RECRUITING
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI